Drug: gemcitabine Quarter: 2016Q3
Total Records: 1,060 Number of Pages: 53
DRUGNAME | PT | EventCount |
---|---|---|
GEMCITABINE | Blood glucose increased | 2 |
GEMCITABINE | Bone marrow toxicity | 2 |
GEMCITABINE | Cerebral haemorrhage | 2 |
GEMCITABINE | Cerebral infarction | 2 |
GEMCITABINE | Cholangiectasis acquired | 2 |
GEMCITABINE | Cholecystitis | 2 |
GEMCITABINE | Cholecystitis infective | 2 |
GEMCITABINE | Chromosomal deletion | 2 |
GEMCITABINE | Chronic obstructive pulmonary disease | 2 |
GEMCITABINE | Clostridial infection | 2 |
GEMCITABINE | Cognitive disorder | 2 |
GEMCITABINE | Diabetic ketoacidosis | 2 |
GEMCITABINE | Disorientation | 2 |
GEMCITABINE | Disseminated intravascular coagulation | 2 |
GEMCITABINE | Duodenal stenosis | 2 |
GEMCITABINE | Dyspepsia | 2 |
GEMCITABINE | Dysplasia | 2 |
GEMCITABINE | Ejection fraction decreased | 2 |
GEMCITABINE | Failure to thrive | 2 |
GEMCITABINE | Folliculitis | 2 |
Total Records: 1,060 Number of Pages: 53